Inovio Pharmaceuticals (INO) Stock Highlights

1.84 | -0.54%

2024-12-21 06:36:50

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Statistics

Range Today

1.75 1.85

Volume Today 1.44M

Range 1 Year

1.74 14.75

Volume 1 Year 117.99M

Range 3 Year

1.74 77.76

Volume 3 Year 347.88M

Range 10 Year

1.74 405.48

Volume 10 Year 1.18B

Highlights

Market Capitalization 143.84M (small)

Floating Shares 23.48M

Current Price 1.84

Price To Earnings -1.08

Price To Revenue 78.4

Price To Book 1.49

Earnings Per Share -5.11

Payout Ratio 0%

Performance

Latest -0.54%

1 Month -53.54%

3 Months -72.29%

6 Months -78.35%

1 Year -60.68%

3 Years -97.63%

5 Years -95.67%

10 Years -98.38%

Benchmarks

Market Capitalization

224 / 368

Gross Profits

261 / 278

Total Revenue

240 / 300

Total Rank

160 / 368

Free Cashflow

289 / 352

Performance 5 years

322 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.